Brief: New Drug Filing For Cenobamate Accepted For Review In Canada And Israel
09/08/2022 16:26
Aug 9 (Reuters) - Endo International PLC ENDP.O :
* NEW DRUG FILING FOR CENOBAMATE ACCEPTED FOR REVIEW IN CANADA AND ISRAEL
Source text for Eikon: ID:nPn9zVSK9a
Further company coverage: ENDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes